Tablet Formulation of 2-((3-(Chloromethyl)benzoyl)oxy)benzoic Acid by Linear and Quadratic Models
Ontology highlight
ABSTRACT:
SUBMITTER:
PROVIDER: S-EPMC9520729 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
Similar Datasets
Project description:The 2-((4-(chloromethyl)benzoyl)oxy)benzoic acid (4CH2Cl) is a potential analgesic compound derived from salicylic acid and 4-chloromethyl benzoyl chloride. Characterization required 4CH2Cl for the formulation of tablet dosage forms. This study aims investigate the effect of SSG, PVP-K30, and the combination of SSG*PVP K-30 on the formulation of 4CH2Cl tablets. Additionally, this study aimed to obtain the optimum 4CH2Cl tablet composition. The experiment followed the two-factor simplex lattice design and direct compression method. The analgesic activity of 4CH2Cl in the optimal tablet was investigated using the hot-plate methods. The ANOVA of linear models is acceptable and the polynomial coefficients of quadratic models are similar to those of linear models. The coefficient of the linear model shows that SSG and PVP K-30 increase the Carr index (16.26; 20.61), Hausner ratio (1.19; 1.29), hardness (4.19; 9.39), friability (0.48; 0.67), disintegration time (0.34; 7.50), and drug release (85.29; 97.69). The coefficient of the quadratic model shows that SSG*PVP K-30 increased the Carr index (1.90), Hausner ratio (0.04), hardness (1.88), friability (0.06), and drug release (4.56), and decreased disintegration time (-0.30). SSG and PVP K-30 increased Carr index, Hausner ratio, hardness, friability, disintegration time, and drug release. The combination of SSG*PVP K-30 has the same effect, except that the disintegration time decreased. The optimum tablet formula is 4CH2Cl (300 mg), Ne (75 mg), SSG (33.60 mg), PVP K-30 (22.40 mg), MCC (40 mg), and SDL (up to 800 mg). 4CH2Cl tablets can be a candidate and choice for new analgesic drugs in the future.
| S-EPMC11417518 | biostudies-literature
Project description:Salicylic acid (SA) derivate is well-known for its anti-inflammatory and analgesic activity through cyclooxygenase (COX)-inhibition. Previous studies pointed toward gastric toxicity induced by most salicylic acid derivative compounds, particularly acetylsalicylic acid (ASA). Despite the adverse effect, ASA is still used due to price affordability and additional advantages in preventing platelet aggregation. Recently, a novel salicylic acid derivative called 2-((3 (chloromethyl)benzoyl)oxy)benzoic acid (3-CH2Cl) was introduced as a potential alternative compound to substitute ASA. Preliminary assessment results of COX-2 specificity, toxicity profile, analgesic, anti-inflammatory, and antiplatelet activity have made 3-CH2Cl a promising compound for "new" drug development. This review focuses on the discovery, potential activity, and benefits of 3-CH2Cl and the possible molecular mechanisms of its regulations in health and disease. Thus, this review may prove to be beneficial for the utilization of 3-CH2Cl as a potential alternative drug to substitute ASA.
| S-EPMC9835159 | biostudies-literature
Project description:The title compound, C(16)H(14)O(3), adopts a conformation in which each functional group is almost coplanar with its adjacent ring, while the two aromatic rings are twisted with respect to one another with a dihedral angle of 78.51 (3)°. The compound dimerizes by standard centrosymmetric hydrogen-bonded carboxyl pairing [O⋯O = 2.6218 (11) Å and O-H⋯O = 176 (2)°]. The packing includes two inter-molecular C-H⋯O close contacts with the ketone group.
| S-EPMC2962032 | biostudies-literature
Project description:In the title compound, C(15)H(11)FO(3), the aromatic rings are oriented at a dihedral angle of 69.26 (3)°. In the crystal structure, inversion dimers arise from pairs of inter-molecular O-H⋯O hydrogen bonds, and C-H⋯O hydrogen bonds further consolidate the packing. There are also C-H⋯π contacts between the benzoic acid and 2-fluoro-benzene rings.
| S-EPMC2960007 | biostudies-literature
Project description:In the crystal structure of the title compound, C(14)H(12)O(4), the mol-ecules form classical O-H⋯O hydrogen-bonded carb-oxy-lic acid dimers. These dimers are linked by C-H⋯pi; inter-actions into a three-dimensional network. The benzene rings are oriented at a dihedral angle of 69.6 (3)°.
| S-EPMC3089338 | biostudies-literature
Project description:The title compound, C(16)H(12)O(6), is a common impurity of ortho-acetyl-salicylic acid (aspirin). The benzene rings form a dihedral angle of 81.9 (1)° while the acetyl and carboxyl groups form dihedral angles of 74.0 (1) and 26.4 (2)°, respectively, with the benzene rings to which they are bound. In the crystal, mol-ecules are linked by pairs of O-H⋯O hydrogen bonds between the carboxyl groups, forming inversion dimers.
| S-EPMC3393920 | biostudies-literature
Project description:In the title compound, C(13)H(9)FO(3), the dihedral angle between the two benzene rings is 70.99 (5)°. In the crystal structure, mol-ecules are linked into dimers by centrosymmetric O-H⋯O inter-actions, generating R(2) (2)(8) ring motifs. These dimers are linked into a two-dimensional array, parallel to the ab plane, by two different C-H⋯O inter-actions. A weak C-H⋯π inter-actions is also present.
| S-EPMC2977365 | biostudies-literature
Project description:The title compound, C(10)H(10)O(4), crystallizes with the well-known carb-oxy-lic acid dimer-forming R(2) (2)(8) hydrogen-bond motif. Chains approximately parallel to (-1-12) are then built through C(methyl-ene,phen-yl)-H⋯O(carbon-yl) inter-actions [C(6) and C(8) motifs] with one (meth-yl)C-H⋯π inter-action providing inter-planar binding. The weakness of the latter inter-action is consistent with the difficulty experienced in obtaining suitable single crystals.
| S-EPMC3569790 | biostudies-literature
Project description:In the crystal structure of the title compound, C(13)H(9)ClO(3), the mol-ecules form classical O-H⋯O hydrogen-bonded carb-oxy-lic acid dimers. These dimers are linked by C-H⋯π inter-actions into a three-dimensional network. The benzene rings are oriented at a dihedral angle of 77.8 (1)°.
| S-EPMC3099902 | biostudies-literature
Project description:In the title compound, C(16)H(15)NO(4)·CH(4)O, the dihedral angle between the benzene rings is 75.21 (5)°. The structure is stabilized by an intra-molecular O-H⋯O inter-action [O⋯O = 2.589 (2) Å]. The solvent mol-ecule links symmetry-related mol-ecules of the complex via hydrogen bonds with O⋯O separations of 2.631 (2) and 2.815 (2) Å. C-H⋯O hydrogen bonds are also present.
| S-EPMC2959920 | biostudies-literature